Generics - AstraZeneca, Regulation

Filter

Current filters:

AstraZenecaRegulation

Popular Filters

Actavis wins generic Pulmicort Respules case; challenges AbbVie patent

02-04-2013

US generic drugs maker Actavis (NYSE: ACT) has confirmed that the US District Court for the District…

AbbVieActavisAndroGelAstraZenecaGenericsMarkets & MarketingMen's HealthNorth AmericaPatentsPulmicort RespulesRegulationRespiratory and Pulmonary

US court turns down AstraZeneca FDA injunction; Teva debuts generic Seroquel in UK

26-03-2012

In another setback for Anglo-Swedish drug major AstraZeneca in its fight to delay generic competition…

AstraZenecaEuropeGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalRegulationSeroquelSeroquel XR

Mylan gets OK for generic Crestor in Canada; Rottapharm deal looks dead

18-03-2012

The Canadian subsidiary of US generic drugmaker Mylan (Nasdaq: MYL) has received approval from Health…

AstraZenecaCardio-vascularCrestorEuropeGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaPharmaceuticalRegulationRottapharm

Parexel

Parexel

Back to top